×
About 230 results

ALLMedicine™ Acute Renal Failure Center

Research & Reviews  85 results

Early postoperative complications in pediatric abdominal solid tumor surgery according ...
https://doi.org/10.1007/s00383-022-05163-6
Pediatric Surgery International; User İR, Ardıçlı B et. al.

Jul 14th, 2022 - Postoperative period after abdominal solid tumor surgery is critical regarding complications. This study aimed to detect incidence and treatment of complications. Single center retrospective study including years 2010-2019 for early postoperative ...

Incidence of Acute Renal Failure in Patients Using Levetiracetam Versus Other Antiseizu...
https://doi.org/10.1007/s40264-022-01193-0
Drug Safety; Beau-Lejdstrom R, Hong LS et. al.

Jun 28th, 2022 - Acute kidney injury is an expected adverse drug reaction listed in the European Union (EU) Summary of Product Characteristics (SmPC) for levetiracetam, one of the most widely used modern antiseizure medications (ASMs). We conducted a voluntary pos...

Postsplenectomy morbidity and mortality in patients with immune thrombocytopenic purpur...
https://doi.org/10.1002/jso.26986
Journal of Surgical Oncology; Sharon CE, Straker RJ et. al.

Jun 18th, 2022 - We sought to identify factors associated with 30-day morbidity, and their impact on 30-day mortality, among patients undergoing splenectomy for immune thrombocytopenic purpura (ITP). Using the ACS-NSQIP database, patients undergoing splenectomy fo...

The long-term impact of acute renal failure after aortic arch replacement for acute typ...
https://doi.org/10.1111/jocs.16614
Journal of Cardiac Surgery; Brown JA, Serna-Gallegos D et. al.

May 19th, 2022 - To determine the long-term impact of developing acute renal failure (ARF) on survival after open aortic arch reconstruction for acute type A aortic dissection (ATAAD). This was an observational study of consecutive aortic surgeries from 2007 to 20...

Association Between SGLT2 Inhibitors vs DPP4 Inhibitors and Renal Outcomes Among Patien...
https://doi.org/10.1210/clinem/dgac164
The Journal of Clinical Endocrinology and Metabolism; Au PCM, Tan KCB et. al.

Mar 19th, 2022 - Diabetic kidney disease is a major burden among diabetic patients. Sodium-glucose cotransporter 2 inhibitors (SGLT2is) were shown to reduce renal outcomes in clinical trials and real-world studies. However, head-to-head comparisons with individual...

see more →

News  7 results

Is Misdiagnosis Inevitable?
https://www.medscape.com/viewarticle/860747_3

Mar 28th, 2016 - Errors Due to Atypical Presentation and Rare Diseases Diagnoses can be sidetracked by atypical disease presentation and by rare diseases that the doctor has never seen before. Studies show that most errors involve common diseases. In a 2013 study,...

Ceftriaxone Linked to Renal Failure in Children
https://www.staging.medscape.com/viewarticle/822489

Mar 24th, 2014 - Ceftriaxone used at therapeutic doses is linked to renal stones and pediatric acute renal failure (PARF), with recovery possible on early treatment, according to a retrospective study published online March 24 in Pediatrics. "Ceftriaxone therapy i...

Ceftriaxone Linked to Renal Failure in Children
https://www.medscape.com/viewarticle/822489

Mar 24th, 2014 - Ceftriaxone used at therapeutic doses is linked to renal stones and pediatric acute renal failure (PARF), with recovery possible on early treatment, according to a retrospective study published online March 24 in Pediatrics. "Ceftriaxone therapy i...

Nesiritide Increases Mortality If Acute Renal Failure Occurs
https://www.mdedge.com/familymedicine/article/26154/cardiology/nesiritide-increases-mortality-if-acute-renal-failure-occurs
Family Practice News; Alicia Ault

PHILADELPHIA — Patients with heart failure who are taking nesiritide and who develop acute renal failure may be at an increased risk of death, Dr. Jose Iglesias said at the annual meeting of the American Society of Nephrology.

Acute Kidney Injury Associated With Febuxostat and Allopurinol
https://www.medscape.com/viewarticle/922419

Abstract and Introduction Abstract Background: For patients with recurrent flares of gout, tophi, urate crystal arthropathy, and renal stones, urate-lowering therapies (ULTs, including allopurinol and febuxostat) are the first-line treatment. Due ...

see more →